The Source for Neurovascular News and Education

April 19, 2024


The best outcomes were seen in patients with unfavorable arches—the authors say this deserves further exploration.

 

 

Carotid artery stenting via radial access can be accomplished with a high procedural success rate and low risks of mortality, access-site complications, and cerebrovascular complications, according to a meta-analysis published online June 14, 2019, ahead of print in the Journal of NeuroInterventional Surgery.

 

“A lot of neurointerventionalists are hesitant to do interventions by radial access at the moment, particularly because they are worried about being able to get into the common carotid artery from the radial access,” co-author Kartik Dev Bhatia, MD (Toronto Western Hospital, Canada) told Neurovascular Exchange in an interview. “There have been real concerns about how to get around the tortuosity when you go from the radial access to get to the common carotid artery,” he continued. “But as we get newer and better catheters that are able to do this, I think that it is less and less of a concern. We are now fairly reliably able to get a guide into most arteries from the right radial access.”

 

Operators often hesitate to move away from the techniques that they used during training and have developed a high level of comfort and expertise with, he added, but “the advantages in terms of access-point complications are very significant, especially in patients on dual antiplatelets.”

 

The meta-analysis, led by Tanaporn Jaroenngarmsamer, MD, (Ramathibodi Hospital, Mahidol University, Bangkok, Thailand), pooled data from four retrospective and three prospective studies published between 2007 and 2018. In all, there were 723 patients who underwent carotid artery stenting via radial artery access. The three most recent studies were two-arm trials comparing the radial and femoral approaches.

 

The meta-analysis was limited by statistically significant heterogeneity for the primary outcome of procedural success. The seven eligible studies reported a pooled procedural success rate of 90.8%.

 

Asymptomatic radial artery occlusion occurred in 5.9% and forearm hematoma in 1.4% of patients. The risk of minor stroke/TIA was 1.9% (95% CI 0.6%-3.8%; I2 = 42.3%) and major stroke was 1.0% (95% CI 0.4%-1.8%; I2 = 0%). There were three deaths across the seven studies, resulting in a cumulative mortality rate of 0.6% (95% CI 0.2%-1.3%; I2 = 0%).

 

“Interventional cardiologists are able to achieve a 90% success rate through radial access for carotid artery stenting, so we should be able to at least match that as neurointerventionalists,” said Bhatia. “In addition, the access-site complication rate was very, very low at 0.4%, definitely lower than anyone can achieve with femoral access [in patients] who have dual antiplatelets onboard.”

 

Choose the Best Approach for Each Patient

 

Bhatia pointed out that the studies with the highest success rates included patients with the most difficult arches, such as type III or bovine.

 

“As a result, radial stenting shouldn’t really replace the femoral approach, but rather it is very useful in those patients who are the hardest to [access] from the femoral approach,” he recommended. “Radial access is probably not good for all cases. I think it should be used in conjunction or as an alternative to femoral access for difficult arches. In particular, the lowest success rate [using the radial approach] was in patients with a nonbovine arch of conventional origin of the left common carotid artery, and they are relatively easy to do by femoral access.”

 

The next step, said Bhatia, is to conduct a randomized clinical trial comparing femoral with radial access in patients with unfavorable arches.


 

Source:

Jaroenngarmsamer T, Bhatia KD, Kortman H, et al. Procedural success with radial access for carotid artery stenting: systematic review and meta-analysis. J NeuroIntervent Surg. 2019;Epub ahead of print.

 

Disclosures:

 

Bhatia and Jaroenngarmsamer report no relevant conflicts of interest.





Monday, October 26 2020

Stroke rates for the balloon-expandable device far exceeded those of the Evolut R; conscious...

Read More »

Monday, October 26 2020

Safety goals were met in the trial, but better efficacy may require ensuring complete coverage of...

Read More »

Wednesday, September 23 2020

The findings “reinforce that this is absolutely the right thing to do and that we need to set up...

Read More »

Tuesday, July 21 2020

Whether COVID-19 adds risk by virtue of being a comorbidity or due to direct effects is unknown. A...

Read More »

Friday, May 8 2020

In some cases, large strokes are the first presentation of COVID-19 in younger patients, but...

Read More »

Monday, April 6 2020

Clopidogrel added to rivaroxaban and aspirin increased bleeding with no added protection from limb or...

Read More »

Monday, April 6 2020

Although rivaroxaban patients had more bleeding, the events were not severe and none were...

Read More »

Monday, April 6 2020

The strokes do not appear related to valve thrombosis or structural degeneration, but rather to...

Read More »

Thursday, January 23 2020

A fundamental unanswered question is whether any type of oral anticoagulation is needed in the...

Read More »

Monday, January 6 2020

Though periprocedural results look good, there are some questions about its rapid rise when...

Read More »

Wednesday, August 21 2019

In addition, an infarct in a new territory did not emerge as an independent predictor of...

Read More »

Wednesday, August 21 2019

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short...

Read More »